ישראל - עברית - Ministry of Health

sanofi israel ltd - sevelamer carbonate anhydrous - אבקה להכנת תרחיף - sevelamer carbonate anhydrous 2.4 g/sachet - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney diseasenot on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

ישראל - עברית - Ministry of Health

novartis pharma services ag - clozapine 100 mg - tablets - diazepines, oxazepines, thiazepines and oxepines - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine - אבקה להכנת תמיסה לזריקה - olanzapine 10 mg / 2 ml - diazepines, oxazepines, thiazepines and oxepines - treatment of agitation associated with schizophrenia and bipolar mania.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

אלקליל בעמ - שיפור מראה העור

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - שיפור מראה העור

ישראל - עברית - Ministry of Health

פאור פייפר בעמ - טיפול בקמטים

ישראל - עברית - Ministry of Health

אלקליל בעמ - שיפור מראה העור

ישראל - עברית - Ministry of Health

מיסנס קוסמטיקס בעמ - שיפור מראה העור

ישראל - עברית - Ministry of Health

מיסנס קוסמטיקס בעמ - לחות לפנים